Biology of Blood and Marrow Transplantation
Volume 14, Issue 9, Supplement , Pages 29-36 , September 2008

Recovery and Safety Profiles of Marrow and PBSC Donors: Experience of the National Marrow Donor Program

  • John P. Miller

      Affiliations

    • National Marrow Donor Program, Minneapolis, Minnesota
  • ,
  • Elizabeth H. Perry

      Affiliations

    • Memorial Blood Centers, St. Paul, Minnesota
  • ,
  • Thomas H. Price

      Affiliations

    • Puget Sound Blood Center, Seattle, Washington
  • ,
  • Charles D. Bolan Jr.

      Affiliations

    • Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland
  • ,
  • Chatchada Karanes

      Affiliations

    • City of Hope National Medical Center, Duarte, California
  • ,
  • Theresa M. Boyd

      Affiliations

    • American Red Cross, Washington, DC
  • ,
  • Pintip Chitphakdithai

      Affiliations

    • National Marrow Donor Program, Minneapolis, Minnesota
  • ,
  • Roberta J. King

      Affiliations

    • National Marrow Donor Program, Minneapolis, Minnesota
    • Corresponding Author InformationCorrespondence and reprint requests: Roberta J. King, MPH, National Marrow Donor Program, 3001 Broadway Street NE, Suite 100, Minneapolis, MN 55413.

Received 23 May 2008 ,Accepted 27 May 2008.

  • Image Result

    (A) Percentage of BM donors reporting pain at selected sites over time. Reports of pain and pain severity were collected at the indicated time points post-donation. Throat pain is largely restricted t

    (A) Percentage of BM donors reporting pain at selected sites over time. Reports of pain and pain severity were collected at the indicated time points post-donation. Throat pain is largely restricted to donors receiving general anesthesia, whereas headache is more common in donors receiving regional anesthesia, for example, epidural. (B) Six most frequently reported body symptoms experienced by BM donors at the indicated time points post-donation.

  • Image Result
    (A) Percentage of PBSC donors reporting bone pain over time. Reports of bone pain and severity of pain were collected at the indicated time points during mobilization, collection, and post-donation. D

    (A) Percentage of PBSC donors reporting bone pain over time. Reports of bone pain and severity of pain were collected at the indicated time points during mobilization, collection, and post-donation. Day 1 is the first day of filgrastim administration; day 5 is the first day of apheresis. Bone pain represents pain in at least one of the following sites: general bone pain, back, head, limb, joint, hip, and neck. The severity of bone pain is defined as the maximum grade among these pain sites. (B) Six most frequently reported body symptoms experienced by PBSC donors during mobilization and collection, and at the indicated time points post-donation. The percentages for day 1 to day 6 represent the frequencies of the highest grade of symptoms during mobilization and collection.

  • Image Result
    Box and whiskers plot of BM donor hemoglobin levels showing the maximum, upper quartile, median, lower quartile, and minimum values at baseline, the day of collection, and the indicated time points po

    Box and whiskers plot of BM donor hemoglobin levels showing the maximum, upper quartile, median, lower quartile, and minimum values at baseline, the day of collection, and the indicated time points post-donation.

  • Image Result
    (A) Box and whiskers plot of PBSC donor WBC counts showing the maximum, upper quartile, median, lower quartile, and minimum values at the indicated time points during mobilization, collection, and pos

    (A) Box and whiskers plot of PBSC donor WBC counts showing the maximum, upper quartile, median, lower quartile, and minimum values at the indicated time points during mobilization, collection, and post-donation. (B) Box and whiskers plot of PBSC donor platelet counts showing the maximum, upper quartile, median, lower quartile, and minimum values at the indicated time points during mobilization, collection, and post-donation. (C) Box and whiskers plot of PBSC donor hemoglobin levels showing the maximum, upper quartile, median, lower quartile, and minimum values at the indicated time points during mobilization, collection, and post-donation. (Day 1 is the first day of filgrastim administration; day 5 is the first day of apheresis; pre and post refer to the apheresis procedure.)

  • Image Result
    Kaplan-Meier plots of time to recovery from stem cell donation (first donations performed from November 2001 through March 2006).

    Kaplan-Meier plots of time to recovery from stem cell donation (first donations performed from November 2001 through March 2006).

 STATEMENT OF CONFLICT OF INTEREST: See Acknowledgements on page 36.

PII: S1083-8791(08)00229-2

doi: 10.1016/j.bbmt.2008.05.018

Biology of Blood and Marrow Transplantation
Volume 14, Issue 9, Supplement , Pages 29-36 , September 2008